ClinicalTrials.gg
RecruitingNCT07749833AI-LBDUpdated Oct 21, 2026

EFFICACY OF ARTIFICIAL INTELLIGENCE DRIVEN PROGRAM VERSUS TRADITIONAL PHYSICAL THERAPY PROGRAM IN PATIENTS WITH LOW BACK DYSFUNCTION

An interventional study of AI-Driven Rehabilitation Program and Traditional Physical Therapy Program in Low Back Pain and Low Back Dysfunction, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Aug 2026; still recruiting 3 months later.
Updated Oct 21, 2026Now RecruitingStudy completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
68
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 74 studies in Low Back Pain by Cairo University — 33 open to participants now, 33 under way, none of them phase 3. Low Back Pain · Cairo University.

Planned enrollment
11th of 65
68 · median 60
Started
2026
with 8 others
No phase
65 of 74
29 open now
Primary completion
2026-12
later than 28 of 32 live
Registered
72nd of 74
by date

Among the 74 studies in Low Back Pain by Cairo University, this one is the 11th largest by planned enrollment of the 65 interventional ones that give a count, is one of 9 that started in 2026, is one of 65 with no phase, reaches primary completion later than 28 of the 32 other live ones, and was the 72nd registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

33 of the 74 studies in Low Back Pain by Cairo University are open now, in 2 countries. Recruiting first, the newest first:

27 more — sign in →

By country, each count listing its studies:

All 33 open studies →

Where they have run

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years to 45 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 74 studies in Low Back Pain by Cairo University, or all of them as a file.
02

Study summary

Low back dysfunction is one of the most common musculoskeletal disorders and is associated with pain, disability, and reduced quality of life. Artificial intelligence (AI) has emerged as a promising tool to support personalized rehabilitation by improving exercise prescription, monitoring adherence, and providing real-time feedback. This randomized controlled trial aims to compare the effectiveness of an AI-driven rehabilitation program with a traditional physical therapy program in patients with low back dysfunction. Primary outcomes include pain intensity, functional disability, and quality of life. The findings may provide evidence regarding the role of AI-assisted rehabilitation in improving clinical outcomes.

Read the detailed description

This study is a prospective randomized controlled trial designed to evaluate the efficacy of an artificial intelligence-driven rehabilitation program compared with a traditional physical therapy program in patients with low back dysfunction. Eligible participants will be randomly allocated into two groups. The experimental group will receive an AI-driven rehabilitation program, while the control group will receive a standardized traditional physical therapy program. Clinical outcomes will be assessed before and after the intervention using validated outcome measures for pain, functional disability, quality of life, and other variables specified in the study protocol. The study aims to determine whether integrating artificial intelligence into rehabilitation provides superior clinical outcomes compared with conventional physical therapy.

03

Conditions studied

  • Low Back Pain
  • Low Back Dysfunction

Browse trials for

Keywords

  • Artificial Intelligence
  • Low Back Dysfunction
  • Low Back Pain
  • Physical Therapy
  • Rehabilitation
  • Exercise Therapy
  • AI-Driven Rehabilitation
  • Musculoskeletal Rehabilitation
  • Randomized Controlled Trial
  • Personalized Rehabilitation
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18-45 years.
  • Male or female participants.
  • Clinical diagnosis of low back dysfunction by a physiotherapist or physician.
  • Symptoms lasting more than 3 months.
  • Ability to participate in physical therapy or use AI-based rehabilitation tools.
  • Willingness to comply with the study protocol and provide written .

Exclusion criteria

Exclusion Criteria:

  • Recent spinal injury or spinal surgery.
  • Previous spinal surgery within the last 6 months.
  • Severe neurological disorders (e.g., multiple sclerosis or Parkinson's disease).
  • Chronic conditions that significantly limit mobility (e.g., advanced arthritis).
  • Current use of strong opioid analgesics.
  • Severe psychiatric disorders.
  • Inability to use or access the required technology for the AI intervention.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
68 participants (estimated)

Study arms

  • Experimental
    AI-Driven Rehabilitation

    Participants will receive an artificial intelligence-driven rehabilitation program including personalized exercise prescription, progression, and monitoring according to the study protocol.

    Other: AI-Driven Rehabilitation Program

  • Active comparator
    Traditional Physical Therapy

    Participants will receive a standardized traditional physical therapy rehabilitation program according to the study protocol.

    Other: Traditional Physical Therapy Program

Interventions

  • OtherAI-Driven Rehabilitation Program

    A personalized rehabilitation program guided by artificial intelligence, including individualized exercise prescription and progression.

  • OtherTraditional Physical Therapy Program

    A conventional physical therapy rehabilitation program delivered according to the study protocol

06

What researchers measure

Primary outcomes

  1. Pain Intensity

    Pain intensity measured using the Visual Analogue Scale (VAS), a 10-cm self-reported pain scale ranging from 0 (no pain) to 10 (worst imaginable pain).

    Time frame: Baseline and immediately post intervention 6 weeks of treatment.

Secondary outcomes

  1. Functional Performance

    Functional performance measured using the Back Performance Scale (BPS). The total score ranges from 0 to 15, with higher scores indicating greater functional limitation.

    Time frame: Baseline and after 6 weeks.

  2. Cost-effectiveness

    Cost-effectiveness assessed using the Incremental Cost-Effectiveness Ratio (ICER), based on total costs and clinical effectiveness of the AI-driven and traditional physical therapy programs,including direct medical costs, intervention-related costs, and healthcare utilization costs.

    Time frame: After completion of the 6-week intervention.

  3. Lumbar Range of Motion

    Lumbar range of motion assessed using the Back Range of Motion (BROM II) device measuring lumbar flexion, extension, lateral flexion, and rotation.

    Time frame: Baseline and after 6 weeks.

07

Study locations

1 of 1 sites recruiting
  • Faculty of Physical Therapy, Cairo University - Research Laboratory
    Giza, Giza Governorate 12613, Egypt
    Recruiting
    • Dalia Youssef, Master degree · Contactdaliayoussef151023@gmail.com · +0201015788109
    • Mohsen El Sayyad, Professor of Physical Therapy · Sub investigator
    • Noran A Elbeheriry, Assistant Professor of PT · Sub investigator
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be publicly shared to protect participant confidentiality and privacy.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2026 (actual). Primary completion is estimated for Dec 2026, 4 months after the start.

Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 4 months is below that.

Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

Completion moved once since we started tracking on Sep 25, 2026: Jan 2027 → May 2027, on Oct 21, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 3, 2026
First posted
Aug 6, 2026
StartActual
Aug 20, 2026
Primary completionEst.
Dec 2026
CompletionEst.
May 2027was Jan 2027
Last update
Oct 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 21, 2026
Sites
1 site added, 1 site removed
Show site
  • Faculty of Physical Therapy, Cairo University - Research Laboratory · Giza, Egypt
Show 1 removed
  • Faculty of Physical Therapy, Cairo University · Cairo, Egypt
Oct 21, 2026
Study completion
Jan 2027→May 2027
Oct 21, 2026
Show all 1 update
  1. Oct 21, 2026
    Not yet recruiting→Recruiting
    1 site added, 1 site removed
    Show site
    • Faculty of Physical Therapy, Cairo University - Research Laboratory · Giza, Egypt
    Show 1 removed
    • Faculty of Physical Therapy, Cairo University · Cairo, Egypt
    Study completion Jan 2027→May 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07749833
Lead sponsor
Cairo University
Responsible party
Dalia Ashraf Mohamed Youssef (Assistant Lecturer and PhD Candidate, Cairo University) — Principal investigator
First posted
Aug 6, 2026
Start date
Aug 20, 2026
Primary completion
Dec 2026 (estimated)
Completion
May 2027 (estimated)
Last update
Oct 21, 2026

Study contacts

Dalia A Youssef, MSc, PT
Contact
Daliayoussef151023@gmail.com
+20 101 578 8109

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion